The Global Sarcopenia Treatments Market Is Expected to Surge At 4.5% CAGR To Reach US$ 3735.2 Million by the End Of 2030.
Sarcopenia Treatments Market Overview
Malnutrition, increased protein and energy needs, weight loss, prolonged immobilization, low-calorie and low-protein diets, low vitamin D levels, an inflammatory state, BMI, and age are some of the factors that contribute to the development of the condition. Despite the study's small sample size and the need for additional research, early sarcopenia diagnosis could aid in managing the condition in COVID-19-affected patients. Therefore, COVID-19 has had an impact on the market for treating sarcopenia as a result of the considerations as mentioned earlier. As a result, the market under investigation has seen gradual expansion.
In addition, rising per capita healthcare costs and a rise in vitamin and nutritional deficiencies in emerging nations are predicted to increase demand for sarcopenia treatment supplements. The rise in occurrences of malnutrition as a result of inadequate dietary intake will also likely present prospects for the sarcopenia therapy industry to expand during the coming years. But in the near future, it's anticipated that the cost of protein supplements will increase and that sarcopenia treatment medications will become more difficult to obtain.
COVID-19 ANALYSIS
The COVID-19 pandemic had an effect on the market for treating sarcopenia since healthcare services were drastically cut back as a result of social alienation policies implemented by governments all over the world. Additionally, the COVID-19 pandemic had an impact on the world economy and negatively impacted normal hospital care for patients who did not have COVID-19 in hospitals around the world. The impact of the presence of sarcopenia upon admission to a post-acute COVID-19 patient rehabilitation unit on body composition and functional and respiratory capacity at discharge was discussed in an article titled "Skeletal Muscle Mass, Sarcopenia, and Rehabilitation Outcomes in Post-Acute COVID-19 Patients" in the Journal of Clinical Medicine in November 2021. According to the article, sarcopenia was discovered in about 58% of COVID-19 patients who were being treated in rehabilitation facilities.
What is our Sarcopenia Treatments Market Scope?
|
Report Attributes
|
Report Details
|
|
Forecast Period 2023 to 2030 CAGR
|
CAGR of 4.5% during the review period (2023 to 2030).
|
|
By Type
|
- Protein Supplement
- Calcium Supplement
- Other
|
|
By Application
|
- Online Pharmacies
- Retail Pharmacies
|
|
By Companies
|
- Abbott Laboratories
- Nestlé
- Pfizer
- Amway
- By-health
- Usana
- A&Z Pharmaceutical
- GlaxoSmithKline
- Bayer
- H&H
- Blackmores
- Zhendong Group
|
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
|
Base Year
|
2021
|
|
Historical Year
|
2016-2021
|
|
Forecast Year
|
2023-2030
|
|
Number of Pages
|
104
|
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Frequently Asked Questions
What is the study period of this market?
The Sarcopenia Treatments Market is studied from 2016-2021
What is the growth rate of the Sarcopenia Treatments Market?
The Sarcopenia Treatments Market is growing at a CAGR of 4.5% over the 7 years.
Who are the Companies in the Sarcopenia Treatments Market?
Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group,
What region does this Sarcopenia Treatments Market report cover?
North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What is the significant Type of Sarcopenia Treatments Market?
Protein Supplement, Calcium Supplement, Other
What is the major Application of the Sarcopenia Treatments Market?
Online Pharmacies, Retail Pharmacies
Who are the Companies in the Sarcopenia Treatments Market?
The Sarcopenia Treatments Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise Application Outlook Types for multiple Application Outlooks. The three dependencies for the status of major Companies in the market are company profile, profitable gross margin, and the prices they charge. The main players are Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group
Industry News
EUGMS 2012 – Advances being made in combining physical and nutritional therapy to mitigate age-related sarcopenia
Nestlé Nutrition Institute satellite symposium held at the European Union Geriatric Medicine Society (EUGMS) congress, in Brussels on 27 September 2012, leading experts examined the evidence showing the synergistic relationship between resistance exercise and supplemental nutrition in the elderly.
What Are The Major Application, And Type Of The Sarcopenia Treatments Market?
By Type, it is segmented into
- Protein Supplement
- Calcium Supplement
- Other
By Application, it is segmented into
- Online Pharmacies
- Retail Pharmacies
Sarcopenia Treatments Market Regional Analysis
Due to the existence of advanced healthcare infrastructure and facilities in nations like the U.S. and Canada, North America is anticipated to have a dominating position in the sarcopenia treatment market. Additionally, because the government has placed a high priority on healthcare in the area, there is a growing demand for sarcopenia treatments. Over the course of the projection period, technological developments are anticipated to support this expansion.
Over the projection period, Europe is anticipated to be the second-largest market for sarcopenia treatments. For instance, the 2019 International Conference on Frailty and Sarcopenia Research featured three oral and poster presentations from Biophytis SA, a Paris (France) business specialising in the discovery of innovative treatments for age-related disorders (ICFSR). The business detailed Sarconeos (BIO 101), its flagship clinical therapeutic candidate, including its background and distinctive mechanism that targets the MAS receptor for preservation of muscular function in muscle wasting condition, in this conference. The business also disclosed the clinical trial layout for its ongoing SARA Phase 2 sarcopenia treatment research using the drug sarcoNEOS.
- North
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- INTRODUCTION
- MARKET DEFINITION
- MARKET DYNAMICS
- MARKET SEGMENTATION
- REPORT TIMELINES
- KEY STAKEHOLDERS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT MATTER EXPERT ADVICE
- QUALITY CHECK
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- EXECUTIVE SUMMARY
- INTRODUCTION
- GLOBAL SARCOPENIA TREATMENTS MARKET, BY TYPES
- GLOBAL SARCOPENIA TREATMENTS MARKET, BY APPLICATIONS
- MARKET DYNAMICS
- DRIVERS
- INCREASING DEMAND FOR SARCOPENIA TREATMENTS MARKET, RESTRAINTS
- STRINGENT ENVIRONMENTAL REGULATIONS
- HIGH COST OF MATERIALS
- OPPORTUNITIES
- SARCOPENIA TREATMENTS MARKET GROWTH
- APPLICATION OF SARCOPENIA TREATMENTS MARKET
- IMPACT OF COVID 19
- GLOBAL SARCOPENIA TREATMENTS MARKET, BY TYPES
- INTRODUCTION
- PROTEIN SUPPLEMENT
- CALCIUM SUPPLEMENT
- GLOBAL SARCOPENIA TREATMENTS MARKET, BY APPLICATION
- INTRODUCTION
- ONLINE PHARMACIES
- RETAIL PHARMACIES
- GLOBAL SARCOPENIA TREATMENTS MARKET, BY REGION
- NORTH AMERICA
- EUROPE
- GERMANY
- FRANCE
- UK
- ITALY
- RUSSIA
- REST OF EUROPE
- APAC
- CHINA
- SOUTH KOREA
- JAPAN
- INDIA
- AUSTRALIA
- ASEAN
- REST OF APAC
- MIDDLE EAST & AFRICA
- SAUDI ARABIA
- UAE
- SOUTH AFRICA
- TURKEY
- REST OF MEA
- SOUTH AMERICA
- BRAZIL
- REST OF MEA
- ARGENTINA
- REST OF SOUTH AMERICA
- COMPETITIVE LANDSCAPE
- MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
- AND AGREEMENTS
- MARKET SHARE /RANKING ANALYSIS
- STRATEGIES ADOPTED BY LEADING PLAYERS
- COMPANY PROFILES
- BUSINESS OVERVIEW
- COMPANY SNAPSHOT
- PRODUCT BENCHMARKING
- STRATEGIC INITIATIVES
- ABBOTT LABORATORIES
- NESTLÉ
- PFIZER
- AMWAY
- BY-HEALTH
- USANA
- A&Z PHARMACEUTICAL
- GLAXOSMITHKLINE
- BAYER
- H&H
- BLACKMORES
- ZHENDONG GROUP
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
